Peter Collins
Amministratore Delegato presso SAGA Diagnostics AB
Profilo
Peter Collins founded European Personalised Medicine Association, where he worked as Director.
Mr. Collins also currently works at SAGA Diagnostics AB, as Chief Executive Officer from 2021.
Mr. Collins also formerly worked at Yourgene Health Plc, as Director & Chief Commercial Officer, GSK Plc, as Vice President & Head-Diagnostics, Riverside Biosciences Ltd., as Principal, BioGenex Laboratories, Inc., as Principal, Gentronix Ltd., as Principal, Pronostics Ltd., as Principal, DxS Ltd., as Senior Vice President-Pharma Business Development, Abbott Molecular Diagnostics, as Vice President-Marketing & Sales, and QIAGEN Ltd., as Vice President-Pharma Business Development.
Posizioni attive di Peter Collins
| Società | Posizione | Inizio |
|---|---|---|
SAGA Diagnostics AB
 SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Amministratore Delegato | 07/10/2021 |
Precedenti posizioni note di Peter Collins
| Società | Posizione | Fine |
|---|---|---|
| YOURGENE HEALTH | Direttore/Membro del Consiglio | 01/11/2018 |
| GSK PLC | Corporate Officer/Principal | - |
Qiagen Ltd.
 Qiagen Ltd. Medical/Nursing ServicesHealth Services Qiagen Ltd. engages in other human health activities. The company was incorporated on October 4, 1993 and is headquartered in Manchester, the United Kingdom | Corporate Officer/Principal | - |
| European Personalised Medicine Association | Fondatore | - |
| Abbott Molecular Diagnostics | Vendite & Marketing | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GSK PLC | Health Technology |
| Aziende private | 10 |
|---|---|
Riverside Biosciences Ltd.
 Riverside Biosciences Ltd. Medical SpecialtiesHealth Technology Riverside Biosciences Ltd. produced neo natal blood testing kits. The company was headquartered in Edinburgh, the United Kingdom. | Health Technology |
BioGenex Laboratories, Inc.
 BioGenex Laboratories, Inc. Pharmaceuticals: MajorHealth Technology BioGenex Laboratories, Inc. provides solutions for automation of cell and tissue testing. It offers automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The company was founded by Krishan L. Kalra and Satya Kalra in 1981 and is headquartered in Fremont, CA. | Health Technology |
Gentronix Ltd.
 Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
Pronostics Ltd.
 Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Pronostics Ltd. operates as a clinical diagnostics company. It offers diagnostic and disease monitoring applications. The company’s products include UltraPlex line of automated multiplexing solutions, such as UltraPlex multiplexed assays to multiplex a range of assays for applications in direct immunoassay; and UltraPlex ANA, a barcoded immunoassay for testing of autoimmune disease biomarkers that allows hospitals and laboratories to perform automated profiles of patient. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
DxS Ltd.
 DxS Ltd. Medical SpecialtiesHealth Technology DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom. | Health Technology |
| Abbott Molecular Diagnostics | |
Qiagen Ltd.
Qiagen Ltd. Medical/Nursing ServicesHealth Services Qiagen Ltd. engages in other human health activities. The company was incorporated on October 4, 1993 and is headquartered in Manchester, the United Kingdom | Health Services |
| European Personalised Medicine Association | |
Yourgene Health Plc
 Yourgene Health Plc Medical SpecialtiesHealth Technology Yourgene Health Plc engages in the development and commercialization of genomic services and technologies. It primarily manufactures molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. It operates through the Genomic Technologies and Genomic Services segments. The Genomic Technologies segment represents the in vitro diagnostic products, software and instrumentation manufactured by the group. The Genomic Services segment operates testing laboratories in Taiwan and the UK, and provides services to clinicians, third party clinical service providers and contract research organizations. The company was founded on April 13, 2000 and is headquartered in Manchester, the United Kingdom. | Health Technology |
SAGA Diagnostics AB
SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Health Services |
- Borsa valori
- Insiders
- Peter Collins
